Table 2 Univariate and multivariate analysis of factors associated with clinical success

Age (%)

0.48–3.15

0.67

  > 72

43 (81)

10 (19)

1

≧72

42 (78)

12 (22)

1.23

Sex (%)

0.15–1.55

0.21

 Male

58 (76)

18 (24)

1

 Female

27 (87)

4 (13)

0.478

History of radiation therapy (%)

0.21–2.23

0.52

 Present

21 (84)

4 (16)

1

 Absent

64 (78)

18 (22)

0.677

Child–pugh (%)

0.52–3.48

0.54

0.047

 A/B

65 (87)

10 (13)

1

1

 C

20 (63)

12 (37)

3.90

2.85

Stage (%)

0.16–1.15

0.086

 I/II/III

41 (82)

9 (18)

1

 IV/V

44 (77)

13 (23)

1.35

BCLC classification (%)

0.175

 0/A/B

27 (93)

2 (7)

1

0.73–5.77

0.16

1

 C/D

20 (26)

58 (74)

4.66

2.84

Portal thrombosis (%)

 Present

36 (75)

12 (25)

1

0.13–1.08

 Absent

49 (83)

10 (17)

0.43

Biliary structure (%)

 Present

76 (81)

18 (19)

1

0.39–3.00

0.83

 Absent

9 (69)

4 (31)

2.01

Cholangitis (%)

 Present

37 (75)

6 (14)

1

 Absent

48 (75)

16 (25)

2.06

Hemobilia (%)

 Present

29 (85)

5 (15)

1

 Absent

56 (77)

17 (23)

1.76

IHBD diameter (%)

≦8 mm

44 (73)

16 (27)

1

  > 8 mm

41 (87)

6 (13)

0.40

Number of stents (%)

≦1

60 (80)

15 (20)

1

  > 1

25 (78)

7 (22)

1.12